Guardant Health
GH
#1571
Rank
โ‚น1.200 T
Marketcap
โ‚น9,242
Share price
0.68%
Change (1 day)
213.52%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น277.33

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น290.65. In 2024 the company made an earnings per share (EPS) of -โ‚น322.34 an increase over its 2023 EPS that were of -โ‚น387.53.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น277.33-13.96%
2024-โ‚น322.34-16.82%
2023-โ‚น387.53-33.13%
2022-โ‚น579.4860%
2021-โ‚น362.1855.04%
2020-โ‚น233.60207.14%
2019-โ‚น76.06-19.81%
2018-โ‚น94.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-โ‚น193.76-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-โ‚น435.25 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA